Inventor · disambiguated record
Rafael Rosell Costa
Also filed as: ROSELL COSTA RAFAEL
0 granted patents·13 pending applications·0 citations·filing 2003–2013
Files withROSELL COSTA RAFAEL5PANGAEA BIOTECH SA4FUNDACION PARA LA INVESTIGACION1PHARMA MAR SA1Pangaea Biotech1
Top patents by PatentIndex Score
13 records- 0160US2010267732A1Prognostic Molecular Markers for ET-743 TreatmentPHARMA MAR SA·Filed 2008·Application pending·0 cites
- 0251US2010009013A1Method of determining a chemotherapeutic regimen for non-small-cell lung cancer based on brca1 expressionPangaea Biotech·Filed 2009·Application pending·0 cites
- 0336US2011142961A1Methods and reagents for predicting clinical outcome and customizing chemotherapy in lung cancer patientsPANGAEA BIOTECH SA·Filed 2009·Application pending·0 cites
- 0435US2011086355A1BRCA1 mRNA EXPRESSION LEVELS PREDICT SURVIVAL IN BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPYPANGAEA BIOTECH SA·Filed 2009·Application pending·0 cites
- 0535US2014113293A1Method for the detection of egfr mutations in blood samplesROSELL COSTA RAFAEL·Filed 2013·Application pending·0 cites
- 0634US2006148736A1Device for assaying polymorphisms of gene xpd/ercc2 for the correct administration of chemotherapy for lung cancerROSELL COSTA RAFAEL·Filed 2003·Application pending·0 cites
- 0734US2008085518A1Assay device of XPD/ERCC2 gene polymorphisms for the correct administration of chemotherapy in lung cancerFUNDACION PARA LA INVESTIGACION·Filed 2007·Application pending·0 cites
- 0830US2010286187A1Method of predicting survival of a non-small-cell lung cancer patient to a chemotherapeutic treatmentPANGAEA BIOTECH SA·Filed 2007·Application pending·0 cites
- 0929US2010167297A1Method of determining the time to progression of non small cell lung cancer after chemotherapy based on thioredoxin expressionROSELL COSTA RAFAEL·Filed 2008·Application pending·0 cites
- 1025US2010167296A1Method of determining a chemotherapeutic regime and survival expectancy for non small cell lung cancer based on egfr/csf-1/ca ix expressionPANGAEA BIOTECH SA·Filed 2008·Application pending·0 cites
- 1123US2011059459A1BRCA1 mRNA EXPRESSION PREDICTS SURVIVAL IN PATIENTS WITH BLADDER CANCER TREATED WITH NEOADJUVANT CISPLATIN-BASED CHEMOTHERAPYTARON ROCA MIGUEL·Filed 2009·Application pending·0 cites
- 1223US2008293725A1Prognostic Molecular MarkersROSELL COSTA RAFAEL·Filed 2005·Application pending·0 cites
- 1316US2012316187A1Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancerROSELL COSTA RAFAEL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rafael Rosell Costa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →